Copyright Reports & Markets. All rights reserved.

Global Alzheimer's Disease Patients Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Alzheimer's Disease Patients

      • 1.1 Definition of Alzheimer's Disease Patients
      • 1.2 Alzheimer's Disease Patients Segment by Type
        • 1.2.1 Global Alzheimer's Disease Patients Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Exelon
        • 1.2.3 Aricept
        • 1.2.4 Namenda
        • 1.2.5 Razadyne
        • 1.2.6 Axura
        • 1.2.7 Ebixa
        • 1.2.8 Nootropil
        • 1.2.9 Prometax
        • 1.2.10 Memac
        • 1.2.11 Eranz
      • 1.3 Alzheimer's Disease Patients Segment by Applications
        • 1.3.1 Global Alzheimer's Disease Patients Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Drug Store
      • 1.4 Global Alzheimer's Disease Patients Overall Market
        • 1.4.1 Global Alzheimer's Disease Patients Revenue (2014-2025)
        • 1.4.2 Global Alzheimer's Disease Patients Production (2014-2025)
        • 1.4.3 North America Alzheimer's Disease Patients Status and Prospect (2014-2025)
        • 1.4.4 Europe Alzheimer's Disease Patients Status and Prospect (2014-2025)
        • 1.4.5 China Alzheimer's Disease Patients Status and Prospect (2014-2025)
        • 1.4.6 Japan Alzheimer's Disease Patients Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Alzheimer's Disease Patients Status and Prospect (2014-2025)
        • 1.4.8 India Alzheimer's Disease Patients Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Alzheimer's Disease Patients
      • 2.3 Manufacturing Process Analysis of Alzheimer's Disease Patients
      • 2.4 Industry Chain Structure of Alzheimer's Disease Patients

      3 Development and Manufacturing Plants Analysis of Alzheimer's Disease Patients

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Alzheimer's Disease Patients Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Alzheimer's Disease Patients
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Alzheimer's Disease Patients Production and Capacity Analysis
      • 4.2 Alzheimer's Disease Patients Revenue Analysis
      • 4.3 Alzheimer's Disease Patients Price Analysis
      • 4.4 Market Concentration Degree

      5 Alzheimer's Disease Patients Regional Market Analysis

      • 5.1 Alzheimer's Disease Patients Production by Regions
        • 5.1.1 Global Alzheimer's Disease Patients Production by Regions
        • 5.1.2 Global Alzheimer's Disease Patients Revenue by Regions
      • 5.2 Alzheimer's Disease Patients Consumption by Regions
      • 5.3 North America Alzheimer's Disease Patients Market Analysis
        • 5.3.1 North America Alzheimer's Disease Patients Production
        • 5.3.2 North America Alzheimer's Disease Patients Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Alzheimer's Disease Patients Import and Export
      • 5.4 Europe Alzheimer's Disease Patients Market Analysis
        • 5.4.1 Europe Alzheimer's Disease Patients Production
        • 5.4.2 Europe Alzheimer's Disease Patients Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Alzheimer's Disease Patients Import and Export
      • 5.5 China Alzheimer's Disease Patients Market Analysis
        • 5.5.1 China Alzheimer's Disease Patients Production
        • 5.5.2 China Alzheimer's Disease Patients Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Alzheimer's Disease Patients Import and Export
      • 5.6 Japan Alzheimer's Disease Patients Market Analysis
        • 5.6.1 Japan Alzheimer's Disease Patients Production
        • 5.6.2 Japan Alzheimer's Disease Patients Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Alzheimer's Disease Patients Import and Export
      • 5.7 Southeast Asia Alzheimer's Disease Patients Market Analysis
        • 5.7.1 Southeast Asia Alzheimer's Disease Patients Production
        • 5.7.2 Southeast Asia Alzheimer's Disease Patients Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Alzheimer's Disease Patients Import and Export
      • 5.8 India Alzheimer's Disease Patients Market Analysis
        • 5.8.1 India Alzheimer's Disease Patients Production
        • 5.8.2 India Alzheimer's Disease Patients Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Alzheimer's Disease Patients Import and Export

      6 Alzheimer's Disease Patients Segment Market Analysis (by Type)

      • 6.1 Global Alzheimer's Disease Patients Production by Type
      • 6.2 Global Alzheimer's Disease Patients Revenue by Type
      • 6.3 Alzheimer's Disease Patients Price by Type

      7 Alzheimer's Disease Patients Segment Market Analysis (by Application)

      • 7.1 Global Alzheimer's Disease Patients Consumption by Application
      • 7.2 Global Alzheimer's Disease Patients Consumption Market Share by Application (2014-2019)

      8 Alzheimer's Disease Patients Major Manufacturers Analysis

      • 8.1 Forest Laboratorie
        • 8.1.1 Forest Laboratorie Alzheimer's Disease Patients Production Sites and Area Served
        • 8.1.2 Forest Laboratorie Product Introduction, Application and Specification
        • 8.1.3 Forest Laboratorie Alzheimer's Disease Patients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Eisai
        • 8.2.1 Eisai Alzheimer's Disease Patients Production Sites and Area Served
        • 8.2.2 Eisai Product Introduction, Application and Specification
        • 8.2.3 Eisai Alzheimer's Disease Patients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 H. Lundbeck A/S
        • 8.3.1 H. Lundbeck A/S Alzheimer's Disease Patients Production Sites and Area Served
        • 8.3.2 H. Lundbeck A/S Product Introduction, Application and Specification
        • 8.3.3 H. Lundbeck A/S Alzheimer's Disease Patients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Novartis
        • 8.4.1 Novartis Alzheimer's Disease Patients Production Sites and Area Served
        • 8.4.2 Novartis Product Introduction, Application and Specification
        • 8.4.3 Novartis Alzheimer's Disease Patients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Merz GmbH & Co. KGaA
        • 8.5.1 Merz GmbH & Co. KGaA Alzheimer's Disease Patients Production Sites and Area Served
        • 8.5.2 Merz GmbH & Co. KGaA Product Introduction, Application and Specification
        • 8.5.3 Merz GmbH & Co. KGaA Alzheimer's Disease Patients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Johnson & Johnson
        • 8.6.1 Johnson & Johnson Alzheimer's Disease Patients Production Sites and Area Served
        • 8.6.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.6.3 Johnson & Johnson Alzheimer's Disease Patients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 UCB
        • 8.7.1 UCB Alzheimer's Disease Patients Production Sites and Area Served
        • 8.7.2 UCB Product Introduction, Application and Specification
        • 8.7.3 UCB Alzheimer's Disease Patients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served

      9 Development Trend of Analysis of Alzheimer's Disease Patients Market

      • 9.1 Global Alzheimer's Disease Patients Market Trend Analysis
        • 9.1.1 Global Alzheimer's Disease Patients Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Alzheimer's Disease Patients Regional Market Trend
        • 9.2.1 North America Alzheimer's Disease Patients Forecast 2019-2025
        • 9.2.2 Europe Alzheimer's Disease Patients Forecast 2019-2025
        • 9.2.3 China Alzheimer's Disease Patients Forecast 2019-2025
        • 9.2.4 Japan Alzheimer's Disease Patients Forecast 2019-2025
        • 9.2.5 Southeast Asia Alzheimer's Disease Patients Forecast 2019-2025
        • 9.2.6 India Alzheimer's Disease Patients Forecast 2019-2025
      • 9.3 Alzheimer's Disease Patients Market Trend (Product Type)
      • 9.4 Alzheimer's Disease Patients Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Alzheimer's Disease Patients Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Alzheimer’s is a complex disease，though many marketed drugs have been approved for Alzheimer’s disease, but it still remains a significant area of unmet medical need. Currently there’s no cure for Alzheimer’s and its still waiting for its key product, numerous companies are developing novel treatments.
        As the risk of getting the disease increases with age, the number of patients with the illness to be found in community will depend on the proportion of older people in the group.
        Traditionally, the developed countries have large proportions of elderly people, and so they have many cases of Alzheimer’s disease in the community at one time.
        At the mean time, developing countries are also undergoing a demographic transition so that more and more persons are surviving to an old age.

        The global Alzheimer's Disease Patients market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Alzheimer's Disease Patients volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alzheimer's Disease Patients market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Alzheimer's Disease Patients in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Alzheimer's Disease Patients manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Forest Laboratorie
        Eisai
        H. Lundbeck A/S
        Novartis
        Merz GmbH & Co. KGaA
        Johnson & Johnson
        UCB
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Exelon
        Aricept
        Namenda
        Razadyne
        Axura
        Ebixa
        Nootropil
        Prometax
        Memac
        Eranz

        Segment by Application
        Hospital
        Drug Store

        Buy now